Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians.
bone metastasis
breast cancer
diagnostic imaging
radiotherapy
systemic therapies
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
24 Aug 2020
24 Aug 2020
Historique:
received:
01
05
2020
revised:
13
08
2020
accepted:
20
08
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
The standard care for metastatic breast cancer (MBC) is systemic therapies with imbrication of focal treatment for symptoms. Recently, thanks to implementation of radiological and metabolic exams and development of new target therapies, oligometastatic and oligoprogressive settings are even more common-paving the way to a paradigm change of focal treatments role. In fact, according to immunophenotype, radiotherapy can be considered with radical intent in these settings of patients. The aim of this literature review is to analyze available clinical data on prognosis of bone metastases from breast cancer and benefits of available treatments for developing a practical guide for clinicians.
Identifiants
pubmed: 32846945
pii: cancers12092390
doi: 10.3390/cancers12092390
pmc: PMC7563945
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Rep Pract Oncol Radiother. 2019 May-Jun;24(3):276-280
pubmed: 30948930
J Bone Oncol. 2018 Nov 06;15:004-4
pubmed: 30937279
Breast Cancer. 2012 Jul;19(3):218-37
pubmed: 22532161
J Mech Behav Biomed Mater. 2017 May;69:75-84
pubmed: 28040610
J Radiat Res. 2017 Nov 1;58(6):791-802
pubmed: 28541506
Nat Rev Dis Primers. 2019 Sep 23;5(1):66
pubmed: 31548545
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Nucl Med. 2020 Jun;61(6):799-806
pubmed: 32245899
Semin Cell Dev Biol. 2017 Mar;63:144-153
pubmed: 28087320
N Engl J Med. 2018 Nov 29;379(22):2108-2121
pubmed: 30345906
Br J Cancer. 2015 Mar 3;112(5):809-18
pubmed: 25647014
Oncologist. 2012;17(8):1100-7
pubmed: 22723509
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
Clin Nucl Med. 1999 Sep;24(9):643-8
pubmed: 10478737
Radiother Oncol. 2002 Sep;64(3):275-80
pubmed: 12242115
Radiother Oncol. 2009 Dec;93(3):639-44
pubmed: 19853943
Radiother Oncol. 2018 Jan;126(1):177-180
pubmed: 28943046
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):575-81
pubmed: 20457354
Trials. 2019 Oct 28;20(1):609
pubmed: 31661034
Eur J Cancer Care (Engl). 2017 Nov;26(6):
pubmed: 28873239
World J Radiol. 2015 Aug 28;7(8):202-11
pubmed: 26339464
Oncologist. 2012;17(12):1496-503
pubmed: 23006498
Oncotarget. 2017 Apr 25;8(17):27990-27996
pubmed: 28427196
Cancer. 2008 Nov 15;113(10):2816-22
pubmed: 18846565
J Clin Oncol. 2017 Nov 10;35(32):3638-3646
pubmed: 28968163
Asia Pac J Clin Oncol. 2019 Mar;15 Suppl 2:14-19
pubmed: 30859749
Cancer. 2004 Dec 1;101(11):2687-92
pubmed: 15493037
Oncotarget. 2016 Feb 9;7(6):7055-65
pubmed: 26755645
JAMA. 1994 May 25;271(20):1593-7
pubmed: 7848404
J Clin Oncol. 2003 Feb 15;21(4):588-92
pubmed: 12586793
Radiat Oncol J. 2015 Dec;33(4):301-9
pubmed: 26756030
Ann Nucl Med. 2019 Mar;33(3):193-200
pubmed: 30569442
Int J Dev Biol. 2004;48(5-6):599-606
pubmed: 15349834
Lancet Oncol. 2018 Jul;19(7):904-915
pubmed: 29804902
Oncogene. 2015 Jun;34(26):3349-56
pubmed: 25220415
Nucl Med Commun. 2000 Jul;21(7):623-6
pubmed: 10994664
Ann Oncol. 2014 Feb;25(2):467-71
pubmed: 24355488
Lancet Oncol. 2009 Jun;10(6):606-14
pubmed: 19482249
J Clin Oncol. 2007 Apr 10;25(11):1423-36
pubmed: 17416863
Front Endocrinol (Lausanne). 2019 Aug 29;10:587
pubmed: 31555210
Ann Oncol. 2014 Dec;25(12):2357-2362
pubmed: 25231953
Radiat Res. 2004 Feb;161(2):228-34
pubmed: 14731066
Oncotarget. 2017 Jul 7;8(40):69105-69124
pubmed: 28978184
Neurosurgery. 2019 Feb 1;84(2):435-441
pubmed: 29547929
Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1254-1258
pubmed: 29439885
Oncogene. 2004 Jan 15;23(2):535-45
pubmed: 14724581
Pract Radiat Oncol. 2019 Mar;9(2):e142-e148
pubmed: 30385151
Med Oncol. 2010 Dec;27(4):1415-9
pubmed: 20041318
Tumori. 2016 Oct 13;102(5):433-440
pubmed: 27716873
EFORT Open Rev. 2017 Sep 1;2(9):372-381
pubmed: 29071122
Int J Radiat Oncol Biol Phys. 1985 Oct;11(10):1751-7
pubmed: 4044337
Breast Cancer. 2019 Mar;26(2):138-146
pubmed: 30324552
J Clin Oncol. 2004 Aug 15;22(16):3302-8
pubmed: 15310773
FEBS J. 2013 Aug;280(15):3551-62
pubmed: 23590234
J Clin Oncol. 2015 Apr 1;33(10):1136-42
pubmed: 25713436
Diagnostics (Basel). 2018 Jul 09;8(3):
pubmed: 29987207
Radiother Oncol. 1997 Nov;45(2):129-32
pubmed: 9424002
Cancer Res. 1999 Mar 15;59(6):1347-55
pubmed: 10096569
Breast Cancer Res Treat. 2014 Jun;145(2):411-8
pubmed: 24728613
J Clin Oncol. 2000 Dec 1;18(23):3925-35
pubmed: 11099322
Trials. 2020 Jan 15;21(1):89
pubmed: 31941523
Oncotarget. 2016 Jul 19;7(29):45186-45198
pubmed: 27286256
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1730-7
pubmed: 21489705
J Oncol Pract. 2016 Jan;12(1):6-10
pubmed: 26759458
J Clin Oncol. 2009 Aug 1;27(22):3611-9
pubmed: 19470941
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):203-11
pubmed: 15629613
Lancet Oncol. 2016 Apr;17(4):425-439
pubmed: 26947331
Lancet. 2011 Mar 12;377(9769):914-23
pubmed: 21376385
Int J Clin Oncol. 2005 Apr;10(2):103-11
pubmed: 15864695
Support Care Cancer. 2019 Feb;27(2):505-512
pubmed: 29980908
Clin Orthop Relat Res. 2002 Mar;(396):191-6
pubmed: 11859243
Adv Radiat Oncol. 2019 Apr 03;4(3):453-457
pubmed: 31360799
Cancer Biother Radiopharm. 2014 Feb;29(1):1-11
pubmed: 24180669
Cancer. 2005 Nov 15;104(10):2244-54
pubmed: 16216003
Clin Nucl Med. 2014 Feb;39(2):e146-59
pubmed: 23579973
N Engl J Med. 2016 Nov 17;375(20):1925-1936
pubmed: 27959613
Nature. 2016 Dec 22;540(7634):552-558
pubmed: 27974799
Trials. 2015 Dec 16;16:575
pubmed: 26673577
Front Oncol. 2019 May 01;9:337
pubmed: 31119099
Eur J Radiol. 2005 Jul;55(1):41-55
pubmed: 15950100
AJR Am J Roentgenol. 2012 Jun;198(6):1387-93
pubmed: 22623553
Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S162-70
pubmed: 15118846
Ann Oncol. 2018 Aug 1;29(8):1634-1657
pubmed: 30032243
Clin Cancer Res. 2005 Jun 15;11(12):4451-9
pubmed: 15958630
Lancet Oncol. 2013 Jan;14(1):e28-37
pubmed: 23276369
Cancer. 1997 Oct 15;80(8 Suppl):1546-56
pubmed: 9362421
Nat Commun. 2016 Oct 04;7:13019
pubmed: 27698471
J Neurooncol. 2019 Sep;144(3):583-589
pubmed: 31399935
Rep Pract Oncol Radiother. 2020 Jan-Feb;25(1):113-116
pubmed: 31908604
Mol Cancer Ther. 2003 Nov;2(11):1113-20
pubmed: 14617784
Nat Rev Cancer. 2002 Aug;2(8):584-93
pubmed: 12154351
Breast Cancer Res Treat. 2008 Sep;111(2):203-8
pubmed: 17990102
Cancer. 2016 Jul 15;122(14):2242-50
pubmed: 27206146
Eur Radiol. 2011 Dec;21(12):2604-17
pubmed: 21887484
Breast. 2019 Aug;46:70-74
pubmed: 31100573
Endocr Relat Cancer. 2013 Aug 28;20(5):691-704
pubmed: 23900794
Virchows Arch. 2017 Mar;470(3):275-283
pubmed: 28101678
N Engl J Med. 2017 Jun 22;376(25):2486-2488
pubmed: 28636861
BMC Cancer. 2018 Jan 6;18(1):44
pubmed: 29306325
Int J Cancer. 2001 Nov;94(4):474-9
pubmed: 11745431
JAMA. 1994 May 25;271(20):1587-92
pubmed: 8182811
Nature. 2016 Dec 22;540(7634):588-592
pubmed: 27974798
Radiother Oncol. 2019 Feb;131:45-51
pubmed: 30773186
Lancet Oncol. 2020 Jan;21(1):e18-e28
pubmed: 31908301